| |
 |
|
Class Information
Number: 424/248.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.)
Description: Subject matter wherein the bacterium is of the genus Mycobacterium.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7625572 |
Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria |
Dec. 1, 2009 |
| 7615222 |
Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
Nov. 10, 2009 |
| 7611720 |
Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
Nov. 3, 2009 |
| 7608279 |
Vaccine formulations |
Oct. 27, 2009 |
| 7608277 |
Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
Oct. 27, 2009 |
| 7608256 |
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response |
Oct. 27, 2009 |
| 7608246 |
Apolipoprotein E as an adjuvant for lipid antigens |
Oct. 27, 2009 |
| 7604953 |
Bioamplification for microbial sensor signal transduction |
Oct. 20, 2009 |
| 7601350 |
Antibodies that bind M. tuberculosis polypeptides |
Oct. 13, 2009 |
| 7601358 |
Mycobacterium tuberculosis protein composition |
Oct. 13, 2009 |
| 7601357 |
Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
Oct. 13, 2009 |
| 7597896 |
Composition comprising a protein encoded by a modified ERP gene of Mycobacterium |
Oct. 6, 2009 |
| 7595383 |
Secreted proteins of Mycobacterium tuberculosis and their use as vaccines and diagnostic reagents |
Sep. 29, 2009 |
| 7592135 |
High resolution typing system for pathogenic Mycobacterium tuberculosum |
Sep. 22, 2009 |
| 7582300 |
Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
Sep. 1, 2009 |
| 7579003 |
HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof |
Aug. 25, 2009 |
| 7579141 |
Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
Aug. 25, 2009 |
| 7579012 |
Targeting of triacylglycerol synthase gene for tuberculosis treatment |
Aug. 25, 2009 |
| 7575870 |
Assay method for peptide specific T-cells |
Aug. 18, 2009 |
| 7575877 |
Method of diagnosing tuberculosis |
Aug. 18, 2009 |
| 7572597 |
Diagnostics method |
Aug. 11, 2009 |
| 7566459 |
Modified mycobacterium tuberculosis strains and uses thereof |
Jul. 28, 2009 |
| 7550144 |
Prion inhibition |
Jun. 23, 2009 |
| 7547506 |
Peptide-based fluorescence polarization assay for detection of antibodies to Mycobacterium bovis |
Jun. 16, 2009 |
| 7541039 |
Immunization with bacterial ghost-based vaccines |
Jun. 2, 2009 |
| 7538206 |
Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
May. 26, 2009 |
| 7534443 |
Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient |
May. 19, 2009 |
| 7527788 |
Desaturase antigen of Mycobacterium tuberculosis |
May. 5, 2009 |
| 7521040 |
Immunotherapy for humans |
Apr. 21, 2009 |
| 7510848 |
Prion protein binding materials and methods of use |
Mar. 31, 2009 |
| 7476530 |
Mycobacterium avium subspecies paratuberculosis oral vaccine and methods |
Jan. 13, 2009 |
| 7468190 |
Reduction in the virulence of Mycobacterium tuberculosis and protection against tuberculosis by means of phoP gene inactivation |
Dec. 23, 2008 |
| 7439041 |
Prion-specific peptide reagents |
Oct. 21, 2008 |
| 7422869 |
Method for diagnosing infectious diseases |
Sep. 9, 2008 |
| 7393539 |
Mycobacterial antigens expressed under low oxygen tension |
Jul. 1, 2008 |
| 7393540 |
Mycobacterial antigens expressed during latency |
Jul. 1, 2008 |
| 7393541 |
Mycobacterial vaccine |
Jul. 1, 2008 |
| 7387886 |
Prion protein dimers useful for vaccination |
Jun. 17, 2008 |
| 7387773 |
Vaccine |
Jun. 17, 2008 |
| 7364740 |
Molecular differences between species of the M. tuberculosis complex |
Apr. 29, 2008 |
| 7361348 |
Immunogenic glycopeptides, screening, preparation and uses |
Apr. 22, 2008 |
| 7344703 |
Mycobacterial sulfation pathway proteins and methods of use thereof |
Mar. 18, 2008 |
| 7335480 |
Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
Feb. 26, 2008 |
| 7335369 |
Fusion proteins of mycobacterium tuberculosis antigens and their uses |
Feb. 26, 2008 |
| 7332340 |
Process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis |
Feb. 19, 2008 |
| 7311922 |
Fusion proteins of mycobacterium tuberculosis |
Dec. 25, 2007 |
| 7300660 |
Abundant extracellular products and methods for their production and use |
Nov. 27, 2007 |
| 7288261 |
Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
Oct. 30, 2007 |
| 7279170 |
32-kDa protein derived from Mycobacterium tuberculosis and related peptides |
Oct. 9, 2007 |
| 7276350 |
Method for diagnosing infectious diseases |
Oct. 2, 2007 |
|
|
|
